Literature DB >> 3059902

[Multiple autoimmune syndromes].

P Humbert1, J L Dupond.   

Abstract

The possibility of three or more autoimmune diseases occurring in the same patient cannot be fortuitous and suggests a pathogenic relationship between each of them. In the light of 4 personal cases, the authors have recorded 87 reports of such associations in the literature, an analysis of which leads them to propose a classification of three types of multiple autoimmune syndrome. The grouping of these syndromes under a single heading should make the research and analysis of these morbid associations easier. Moreover, the classification adopted by the authors allows a more precise definition of patients with at least two autoimmune diseases and so helps to recognize the onset of a third autoimmune disease at a later date. Multiple autoimmune syndromes can be classified in 3 groups according to the prevalence of their associations one with another. Type I comprises myasthenia, thymoma, polymyositis and giant cell myocarditis, this association having a single pathogenic mechanism. Type II includes the Sjögren's syndrome, rhumatoid arthritis, primary biliary cirrhosis, scleroderma and autoimmune thyroid disorders. Type III groups together 10 autoimmune diseases (autoimmune thyroid disease, myasthenia and/or thymoma, Sjögren's syndrome, pernicious anaemia, idiopathic thrombocytopaenic purpura, Addison's disease, insulin-dependent diabetes, vitiligo, autoimmune haemolytic anaemia, systemic lupus erythematosus) for which a genetic predisposition (phenotype HLA B8 and/or DR3 or DR5) seems to be an important factor.

Entities:  

Mesh:

Year:  1988        PMID: 3059902

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  22 in total

1.  The multiple autoimmune syndromes. A clue for the autoimmune tautology.

Authors:  Juan-Manuel Anaya; John Castiblanco; Adriana Rojas-Villarraga; Ricardo Pineda-Tamayo; Roger A Levy; José Gómez-Puerta; Carlos Dias; Ruben D Mantilla; Juan Esteban Gallo; Ricard Cervera; Yehuda Shoenfeld; Mauricio Arcos-Burgos
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  A coincidence of rheumatoid arthritis, autoimmune thyroid disease and vitiligo in a single patient: a possible pathogenetic linkage.

Authors:  Meltem Alkan Melikoğlu; Mehmet Melikoğlu; Saliha Karatay; Mahir Uğur; Kazım Şenel
Journal:  Eurasian J Med       Date:  2008-04

3.  Syndrome in question. Multiple autoimmune syndrome.

Authors:  Guida Santos; Lourdes Sousa
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

4.  Abnormal thyroid function test results in patients with Fisher-Evans syndrome.

Authors:  S Lio; M Albin; G Girelli; M P Perrone; G Gandolfo; L Conti; D Mazzone; M D'Armiento
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

5.  Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment.

Authors:  M Ottesen; U Feldt-Rasmussen; J Andersen; E Hippe; A Schouboe
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

6.  POLYGLANDULAR AUTOIMMUNE SYNDROME ASSOCIATED WITH MULTIPLE AUTOIMMUNE CONDITIONS AND ATOPIC DERMATITIS - AN UNUSUAL MANIFESTATION OF A POLYAUTOIMMUNITY PHENOTYPE.

Authors:  A M Forsea; C Mihai; T Predescu; I Tudose; I Margaritescu; C Giurcaneanu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

7.  Optimal management of pernicious anemia.

Authors:  Emmanuel Andres; Khalid Serraj
Journal:  J Blood Med       Date:  2012-09-10

8.  PBC: Animal Models of Cholangiopathies and Possible Endogenous Viral Infections.

Authors:  Masashi Ninomiya; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Int J Hepatol       Date:  2011-08-08

9.  Alopecia areata and autoimmunity: a clinical study.

Authors:  Emy Abi Thomas; R S Kadyan
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 10.  How do autoimmune diseases cluster in families? A systematic review and meta-analysis.

Authors:  Jorge Cárdenas-Roldán; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  BMC Med       Date:  2013-03-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.